blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3279659

EP3279659 - REAGENT AND METHOD FOR ASSAYING THROMBIN-ANTITHROMBIN COMPLEX [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.12.2022
Database last updated on 16.09.2024
FormerThe patent has been granted
Status updated on  14.01.2022
FormerGrant of patent is intended
Status updated on  14.10.2021
FormerExamination is in progress
Status updated on  05.11.2019
FormerRequest for examination was made
Status updated on  05.01.2018
FormerThe international publication has been made
Status updated on  13.10.2017
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024 [2024/42]
Applicant(s)For all designated states
LSI Medience Corporation
13-4, Uchikanda 1-chome
Chiyoda-ku
Tokyo 101-8517 / JP
[2018/06]
Inventor(s)01 / YOSHIDA, Tatsuya
c/o LSI MEDIENCE CORPORATION
13-4 Uchikanda 1-chome
Chiyoda-ku
Tokyo 101-8517 / JP
02 / YANG, Yuhang
c/o LSI MEDIENCE CORPORATION
13-4 Uchikanda 1-chome
Chiyoda-ku
Tokyo 101-8517 / JP
 [2018/06]
Representative(s)Jones, Nicholas Andrew
Withers & Rogers LLP
2 London Bridge
London SE1 9RA / GB
[2022/07]
Former [2018/06]Jones, Nicholas Andrew
Withers & Rogers LLP
4 More London Riverside
London, SE1 2AU / GB
Application number, filing date16772896.329.03.2016
[2018/06]
WO2016JP60261
Priority number, dateJP2015007416831.03.2015         Original published format: JP 2015074168
JP2015007417331.03.2015         Original published format: JP 2015074173
[2018/06]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016159015
Date:06.10.2016
Language:JA
[2016/40]
Type: A1 Application with search report 
No.:EP3279659
Date:07.02.2018
Language:EN
[2018/06]
Type: B1 Patent specification 
No.:EP3279659
Date:16.02.2022
Language:EN
[2022/07]
Search report(s)International search report - published on:JP06.10.2016
(Supplementary) European search report - dispatched on:EP16.10.2018
ClassificationIPC:G01N33/53, G01N33/543
[2018/06]
CPC:
G01N33/86 (EP); G01N33/543 (KR,US); G01N33/573 (CN);
G01N33/54333 (US); G01N33/53 (US); G01N33/5306 (US);
G01N33/54313 (CN); G01N33/54353 (US); G01N33/545 (EP,KR);
G01N33/6854 (KR); G01N33/6893 (CN); G01N2333/8128 (CN,KR);
G01N2333/974 (CN,KR,US); G01N2800/224 (CN); G01N2800/226 (CN) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/06]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:REAGENS UND VERFAHREN ZUM TESTEN VON THROMBIN-ANTITHROMBIN-KOMPLEXEN[2018/06]
English:REAGENT AND METHOD FOR ASSAYING THROMBIN-ANTITHROMBIN COMPLEX[2018/06]
French:RÉACTIF ET PROCÉDÉ DE DOSAGE DE COMPLEXE THROMBINE-ANTITHROMBINE[2018/06]
Entry into regional phase12.10.2017Translation filed 
12.10.2017National basic fee paid 
12.10.2017Search fee paid 
12.10.2017Designation fee(s) paid 
12.10.2017Examination fee paid 
Examination procedure12.10.2017Examination requested  [2018/06]
12.10.2017Date on which the examining division has become responsible
14.05.2019Amendment by applicant (claims and/or description)
08.11.2019Despatch of a communication from the examining division (Time limit: M06)
01.05.2020Reply to a communication from the examining division
23.10.2020Despatch of a communication from the examining division (Time limit: M04)
01.02.2021Reply to a communication from the examining division
15.10.2021Communication of intention to grant the patent
10.01.2022Fee for grant paid
10.01.2022Fee for publishing/printing paid
10.01.2022Receipt of the translation of the claim(s)
Opposition(s)17.11.2022No opposition filed within time limit [2023/04]
Fees paidRenewal fee
12.03.2018Renewal fee patent year 03
11.03.2019Renewal fee patent year 04
12.03.2020Renewal fee patent year 05
12.03.2021Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.03.2016
AL16.02.2022
AT16.02.2022
CY16.02.2022
CZ16.02.2022
DK16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
MC16.02.2022
MK16.02.2022
MT16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SI16.02.2022
SK16.02.2022
SM16.02.2022
IE29.03.2022
LU29.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
[2024/42]
Former [2024/22]HU29.03.2016
AL16.02.2022
AT16.02.2022
CY16.02.2022
CZ16.02.2022
DK16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
MC16.02.2022
MK16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SI16.02.2022
SK16.02.2022
SM16.02.2022
IE29.03.2022
LU29.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2024/20]HU29.03.2016
AL16.02.2022
AT16.02.2022
CY16.02.2022
CZ16.02.2022
DK16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
MC16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SI16.02.2022
SK16.02.2022
SM16.02.2022
IE29.03.2022
LU29.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2024/18]HU29.03.2016
AL16.02.2022
AT16.02.2022
CZ16.02.2022
DK16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
MC16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SI16.02.2022
SK16.02.2022
SM16.02.2022
IE29.03.2022
LU29.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2023/10]AL16.02.2022
AT16.02.2022
CZ16.02.2022
DK16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
MC16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SI16.02.2022
SK16.02.2022
SM16.02.2022
IE29.03.2022
LU29.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2023/09]AL16.02.2022
AT16.02.2022
CZ16.02.2022
DK16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
MC16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SK16.02.2022
SM16.02.2022
IE29.03.2022
LU29.03.2022
CH31.03.2022
LI31.03.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2023/08]AL16.02.2022
AT16.02.2022
CZ16.02.2022
DK16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
MC16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SK16.02.2022
SM16.02.2022
IE29.03.2022
LU29.03.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2023/01]AL16.02.2022
AT16.02.2022
CZ16.02.2022
DK16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
MC16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SK16.02.2022
SM16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2022/49]AT16.02.2022
CZ16.02.2022
DK16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SK16.02.2022
SM16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2022/48]AT16.02.2022
CZ16.02.2022
DK16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SM16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2022/47]AT16.02.2022
DK16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SM16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2022/46]AT16.02.2022
DK16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
PL16.02.2022
RS16.02.2022
SE16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2022/42]AT16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
PL16.02.2022
RS16.02.2022
SE16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2022/39]AT16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
PL16.02.2022
RS16.02.2022
SE16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
Former [2022/36]AT16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
PL16.02.2022
RS16.02.2022
SE16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
Former [2022/35]HR16.02.2022
LT16.02.2022
RS16.02.2022
SE16.02.2022
BG16.05.2022
NO16.05.2022
PT16.06.2022
Former [2022/34]LT16.02.2022
NO16.05.2022
PT16.06.2022
Former [2022/33]LT16.02.2022
NO16.05.2022
Documents cited:Search[X]EP0669344  (DAIICHI PURE CHEMICALS CO LTD [JP]) [X] 1-5 * p.4 l.49, example 4; claims *;
 [I]EP0818680  (DAIICHI PURE CHEMICALS CO LTD [JP]) [I] 1-5 * example 3 *;
 [I]  - TOPPER M J ET AL, "ENZYME-LINKED IMMUNOSORBENT ASSAY FOR THROMBIN-ANTITHROMBIN III COMPLEXES IN HORSES", AMERICAN JOURNAL OF VETERINARY RESEA, AMERICAN VETERINARY MEDICINE ASSOCIATION, US, (19960401), vol. 57, no. 4, ISSN 0002-9645, pages 427 - 431, XP009021666 [I] 1-5 * abstract *
 [I]  - ELGUE G ET AL, "The use of a commercial ELISA for assay of thrombin-antithrombin complexes in purified systems", THROMBOSIS AND HAEMOST, SCHATTAUER GMBH, DE, (19900628), vol. 63, no. 3, ISSN 0340-6245, pages 435 - 438, XP009090946 [I] 1-5 * abstract *
 [X]  - COLLEN D ET AL, "QUANTITATION OF THROMBIN ANTI THROMBIN III COMPLEXES IN HUMAN BLOOD", EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 7, no. 5, doi:10.1111/J.1365-2362.1977.TB01627.X, ISSN 0014-2972, (19771001), pages 407 - 412, (20080320), XP009506572 [X] 1-5 * abstract *

DOI:   http://dx.doi.org/10.1111/j.1365-2362.1977.tb01627.x
International search[A]JPH0348158  (TEIJIN LTD) [A] 1-8* , claim 1 & EP 391433 A2 claim 1 *;
 [Y]JPH07238099  (DAIICHI PURE CHEMICALS CO LTD) [Y] 1-8 * , abstract; paragraphs [0020], [0024], [0028], [0042]; example 4 & EP 669344 A2 abstract; page 4, lines 1 to 46; page 5, lines 20 to 24; page 9, lines 41 to 44; example 4 *;
 [Y]JPH07260788  (SEKISUI CHEMICAL CO LTD) [Y] 2-3, 6-8 * , paragraph [0017]; example 1 (Family: none) *;
 [Y]JPH08110341  (SEKISUI CHEMICAL CO LTD) [Y] 2-3, 6-8 * , paragraph [0006] (Family: none) *;
 [Y]JPH1026621  (DAIICHI PURE CHEMICALS CO LTD) [Y] 1-8 * , examples 3, 4 & EP 818680 A1 examples 3, 4 & US 2001/0007774 A1 *;
 [Y]JP2001289850  (INT REAGENTS CORP) [Y] 1-5 * , paragraphs [0002], [0003] (Family: none) *
ExaminationEP0669344
 EP0818680
    - ASAKURA S ET AL, "Preparation and characterization of monoclonal antibodies against the human thrombin-antithrombin III complex", BIOCHIMICA ET BIOPHYSICA ACTA, ELSEVIER, NL, (19880104), vol. 952, no. 1, ISSN 0006-3002, pages 37 - 47, XP009506557
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.